Skip to main content

Table 2 Laboratory, clinical and imaging findings of the 10 study patients with brucellar spondylitis at the end of treatment

From: Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis

Pt

Duration of treatment (months)

Findings at the end of treatment

Duration of follow-up after treatment discontinuation (months)

ESR mm/hr

CRP mg/L

SAT titers

WBC K/μl

Clinical

MRI residual findings

F-18 FDG PET/CT findings

F-18 FDG PET/CT SUVmax

1

12

40

5.00

1/320

4.70

(−)

L5 – S1

L2 – L3, L5 – S1

3.2 2.6

27

2

12

10

5.00

1/680

6.50

(−)

T7 – T8

T7 – T8, L4 – L5

3.3 2.0

13

3

9

5

3.08

1/ 10240

4.43

(−)

L2 – L3

L3

2.9

21

4

12

35

10.00

1/320

6.65

(−)

L4 – L5

L5 T6

2.6 2.9

10

5

6

15

2.97

< 1/160

7.24

(−)

(−)

(−)

0

9

6

11

15

2.97

1/320

5.15

Back pain on effort

L4 – L5

L4 – L5

2.7

8

7

12

17

3.08

< 1/160

7.85

Pain on weather changes

(−)

T7

2.0

17

8

12

20

4.10

< 1/160

8.90

(−)

(−)

L3

2.0

11

9

6

14

5.00

< 1/160

7.70

(−)

(−)

L3

3.0

21

10

12

23

5.00

< 1/160

4.80

Back pain on effort

L4 – L5

L1 – L2, L4 – L5

2.9 4.4

12

  1. NOTES. Pt: patient number, ESR: erythrocyte sedimentation rate (normal value, 40 mm/hour), CRP: C-reactive protein (normal values < 5 mg/L), WBC: white blood count, SAT: slide agglutination test (normal values < 1/160), MRI: magnetic resonance imaging, F-18 FDG PET/CT: fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography scan, SUVmax: maximum standard uptake value.